• NORD Partners with ‘Sing Me a Story’ for July 18–20 Living Rare Forum
  • Global Rare Disease Group’s Focus: 1,000 New Therapies by 2027, Despite COVID-19
  • AAV Patients at 7 Times Higher Risk for Infections, Study Finds
  • Omitting Rituxan Dose Does Not Affect AAV Relapse Rates, Analysis Suggests
  • AAV Does Not Raise Healthcare Use, Mortality in Goodpasture’s Syndrome, Study Says
  • Pediatric Rare Disease Therapies Increase, But Most Repurposed, Study Finds
  • GPA Patients Undergo More Hospitalizations With Worse Outcomes, US Study Finds
  • Video: BioNews’ Social Media Campaign Highlights #WhatMakesMeRare
  • Lung Involvement Increases Relapse Risk in Chinese Patients With MPO-AAV, Study Says
  • Elsevier Opens Books, Review Articles to Rare Disease Researchers Starting Feb. 29
  • AAV That Involves Central Nervous System Linked to More Active Disease, Chinese Study Suggests
  • Advice on Starting Nonprofit Groups for Rare and Other Diseases Focus of NORD Webinar